Skip to main content
Erschienen in: Clinical and Experimental Nephrology 6/2018

07.06.2018 | Original article

Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan

verfasst von: Daijo Inaguma, Eri Ito, Kazuo Takahashi, Hiroki Hayashi, Shigehisa Koide, Midori Hasegawa, Yukio Yuzawa, AICOPP Group

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

An increasing number of patients worldwide require dialysis as a result of hypertensive nephrosclerosis (HTN). However, in Japan, mortality in patients with end-stage renal disease (ESRD) has not been well by primary kidney disease including HTN and diabetic nephropathy (DN). Hence, we examined the differences in mortality among the primary kidney diseases of incident dialysis patients.

Methods

The study was a multicenter prospective cohort analysis including 1520 incident dialysis patients in Aichi prefecture, Japan. We classified patients into three groups according to the primary kidney disease [i.e., a HTN group, n = 384, a DN group n = 658, and a chronic glomerulonephritis (CGN) group, n = 224]. In addition, we classified patients into the HTN group and the DN group using propensity score matching. We compared outcomes including all-cause and infection-related mortality.

Results

The mortality rates of the HTN, the DN, and the CGN group, were 135.9, 64.2, and 34.8 per 1000 patient years, respectively. All-cause mortality and infection-related mortality rates in the HTN group were as high as those in the DN group after adjustment for age, gender, history of cardiovascular disease, and estimated glomerular filtration rate. No significant difference of all-cause mortality was observed after propensity score matching between the two groups (Logrank test: p = 0.523).

Conclusions

The present study was Japan’s first large-scale prospective cohort to demonstrate that HTN is the second most common cause of ESRD. In addition, the prognosis of patients with HTN was as poor as that of patients with DN.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat United States Renal Data System. Annual Data Report 2017. United States Renal Data System. Annual Data Report 2017.
2.
Zurück zum Zitat Jin DC, Yun SR, Lee SW, Han SW, Kim W, Park J. Current characteristics of dialysis therapy in Korea: 2015 registry data focusing on elderly patients. Kidney Res Clin Pract. 2016;35(4):204–11.CrossRef Jin DC, Yun SR, Lee SW, Han SW, Kim W, Park J. Current characteristics of dialysis therapy in Korea: 2015 registry data focusing on elderly patients. Kidney Res Clin Pract. 2016;35(4):204–11.CrossRef
3.
Zurück zum Zitat ERA-EDTA Registry. Annual report 2015. ERA-EDTA Registry. Annual report 2015.
4.
Zurück zum Zitat Lin YC, Hsu CY, Kao CC, Chen TW, Chen HH, Hsu CC, Wu MS. Incidence and prevalence of ESRD in Taiwan renal registry data system (TWRDS): 2005–2012. Acta Nephrol. 2014;28(2):65–8. Lin YC, Hsu CY, Kao CC, Chen TW, Chen HH, Hsu CC, Wu MS. Incidence and prevalence of ESRD in Taiwan renal registry data system (TWRDS): 2005–2012. Acta Nephrol. 2014;28(2):65–8.
6.
Zurück zum Zitat Ekart R, Ferjuc A, Furman B, Gerjevič Š, Bevc S, Hojs R. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease. Ther Apher Dial. 2013;17(4):363–7.CrossRef Ekart R, Ferjuc A, Furman B, Gerjevič Š, Bevc S, Hojs R. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease. Ther Apher Dial. 2013;17(4):363–7.CrossRef
7.
Zurück zum Zitat Barsoum RS. Burden of chronic kidney disease: North Africa. Kidney Int Suppl. 2013;3(2):164–6.CrossRef Barsoum RS. Burden of chronic kidney disease: North Africa. Kidney Int Suppl. 2013;3(2):164–6.CrossRef
8.
Zurück zum Zitat Sesso RC, Lopes AA, Thomé FS, Lugon JR, Martins CT. Brazilian chronic dialysis Survey 2016. J Bras Nefrol. 2017;39(3):261–6.CrossRef Sesso RC, Lopes AA, Thomé FS, Lugon JR, Martins CT. Brazilian chronic dialysis Survey 2016. J Bras Nefrol. 2017;39(3):261–6.CrossRef
9.
Zurück zum Zitat Hishida M, Tamai H, Morinaga T, Maekawa M, Aoki T, Tomida H, Komatsu S, Kamiya T, Maruyama S, Matsuo S, Inaguma D. Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy. Clin Exp Nephrol. 2016;20(5):795–807.CrossRef Hishida M, Tamai H, Morinaga T, Maekawa M, Aoki T, Tomida H, Komatsu S, Kamiya T, Maruyama S, Matsuo S, Inaguma D. Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy. Clin Exp Nephrol. 2016;20(5):795–807.CrossRef
10.
Zurück zum Zitat Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. MD State Med J. 1965;14:61–5.PubMed Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. MD State Med J. 1965;14:61–5.PubMed
11.
Zurück zum Zitat Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis. 1994;23(5):655–60.CrossRef Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis. 1994;23(5):655–60.CrossRef
12.
Zurück zum Zitat Beevers DG, Lip GY. Does non-malignant essential hypertension cause renal damage? A clinician’s view. J Hum Hypertens. 1996;10(10):695–9.PubMed Beevers DG, Lip GY. Does non-malignant essential hypertension cause renal damage? A clinician’s view. J Hum Hypertens. 1996;10(10):695–9.PubMed
14.
Zurück zum Zitat Oh SW, Kim S, Na KY, Chae DW, Kim S, Jin DC, Chin HJ. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract. 2012;97(3):418–24.CrossRef Oh SW, Kim S, Na KY, Chae DW, Kim S, Jin DC, Chin HJ. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract. 2012;97(3):418–24.CrossRef
15.
Zurück zum Zitat Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl. 2013;48(3):452–8.CrossRef Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl. 2013;48(3):452–8.CrossRef
16.
Zurück zum Zitat Jhund PS, McMurray JJ, Chaturvedi N, Brunel P, Desai AS, Finn PV, Haffner SM, Solomon SD, Weinrauch LA, Claggett BL, Pfeffer MA. Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial. Eur Heart J. 2015;36(36):2463–9.CrossRef Jhund PS, McMurray JJ, Chaturvedi N, Brunel P, Desai AS, Finn PV, Haffner SM, Solomon SD, Weinrauch LA, Claggett BL, Pfeffer MA. Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial. Eur Heart J. 2015;36(36):2463–9.CrossRef
17.
Zurück zum Zitat Hoffmann F, Haastert B, Koch M, Giani G, Glaeske G, Icks A. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol Dial Transpl. 2011;26(5):1634–40.CrossRef Hoffmann F, Haastert B, Koch M, Giani G, Glaeske G, Icks A. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol Dial Transpl. 2011;26(5):1634–40.CrossRef
19.
Zurück zum Zitat Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T. Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development. Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis. Clin Exp Nephrol. 2017. https://doi.org/10.1007/s10157-017-1496-4.CrossRefPubMed Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T. Research Group of Diabetic Nephropathy and Nephrosclerosis, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development. Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis. Clin Exp Nephrol. 2017. https://​doi.​org/​10.​1007/​s10157-017-1496-4.CrossRefPubMed
20.
Zurück zum Zitat Furuichi K, Yuzawa Y, Shimizu M, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T. Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes. Nephrol Dial Transpl. 2017. https://doi.org/10.1093/ndt/gfw417.CrossRef Furuichi K, Yuzawa Y, Shimizu M, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T. Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes. Nephrol Dial Transpl. 2017. https://​doi.​org/​10.​1093/​ndt/​gfw417.CrossRef
Metadaten
Titel
Impact of high mortality in incident dialysis patients due to hypertensive nephrosclerosis: a multicenter prospective cohort study in Aichi, Japan
verfasst von
Daijo Inaguma
Eri Ito
Kazuo Takahashi
Hiroki Hayashi
Shigehisa Koide
Midori Hasegawa
Yukio Yuzawa
AICOPP Group
Publikationsdatum
07.06.2018
Verlag
Springer Singapore
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 6/2018
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1592-0

Weitere Artikel der Ausgabe 6/2018

Clinical and Experimental Nephrology 6/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.